
General Healthcare
4 Jun 2026
New Life-Extending Drug for Women with Ovarian Cancer
A new ovarian cancer drug, mirvetuximab soravtansine, has been approved on the NHS, offering improved survival and better tolerability for patients with treatment-resistant ovarian cancer through a targeted antibody-drug approach.





























